Neumora Therapeutics, Inc.

NMRA · XNAS

CIK 1885522fmd_1H02YV34X97HKQCQP7G97N5VFVManufacturing · Biological Products, (No Diagnostic Substances)Template: Standard

Coverage: Jan 01, 2022 to Jun 30, 2026, 18 periods

Ratios computed from the standardized statements. Select a value to open its proof.